A detailed history of Algert Global LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Algert Global LLC holds 12,676 shares of IDYA stock, worth $380,406. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,676
Previous 36,869 65.62%
Holding current value
$380,406
Previous $1.62 Million 72.5%
% of portfolio
0.01%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $831,513 - $1.05 Million
-24,193 Reduced 65.62%
12,676 $445,000
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $491,796 - $677,729
14,380 Added 63.94%
36,869 $1.62 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $494,996 - $721,257
-20,130 Reduced 47.23%
22,489 $800,000
Q3 2023

Nov 13, 2023

SELL
$21.07 - $29.77 $473,442 - $668,931
-22,470 Reduced 34.52%
42,619 $1.15 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $867,636 - $1.66 Million
65,089 New
65,089 $1.53 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.44B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.